๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-08-19

Pivotal Study of N-acetyl-L-leucine for CACNA1A (NCT07221292)

Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, Randomized, Placebo-controlled, Double-blind, Crossover Study

๐ŸŸข Recruiting Phase3 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: IntraBio Inc

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

A pivotal, randomized, double-blind, placebo-controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of CACNA1A. The objective of this study is to evaluate the safety, tolerability and efficacy of N-acetyl-L-leucine (IB1001) compared to standard of care.

Who can join: Review the eligibility criteria below.

Location: Johns Hopkins University โ€” Baltimore, Maryland

Age range: 4 Years

๐Ÿงช Interventions in This Study

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (10 Sites)

  • Johns Hopkins University โ€” Baltimore, Maryland
  • Massachusetts General Hospital โ€” Boston, Massachusetts
  • The University of Texas Health (UT Health) โ€” Houston, Texas
  • Medical University of Innsbruck โ€” Innsbruck,
  • University of Cologne โ€” Cologne,
  • University of Athens โ€” Athens,
  • University of Milan โ€” Milan,
  • Bambino Gesu' Children's Research Hospital โ€” Rome,
  • University Hospital Bern Inselspital โ€” Bern,
  • University of Oxford - John Radcliffe Hospital โ€” Oxford,

๐Ÿ“ž Contact the Study Coordinator

Phone: +447426956369

Email: tfields@intrabio.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All CACNA1A clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—